Literature DB >> 4433233

[Dopa resorption and dopamin estimation in blood of patients with Parkinson's disease (author's transl)].

E Metzel, W U Weitbrecht.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4433233     DOI: 10.1007/BF00342049

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


× No keyword cloud information.
  16 in total

1.  The fluorimetric estimation of catecholamines.

Authors:  H WEIL-MALHERBE
Journal:  Methods Med Res       Date:  1961

2.  L-dopa in idiopathic parkinsonism.

Authors:  D B Calne; G M Stern; A S Spiers; D R Laurence
Journal:  Lancet       Date:  1969-11-08       Impact factor: 79.321

3.  L-Dopa treatment in Parkinson's Disease.

Authors:  U K Rinne; V Sonninen; T Siirtola
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

4.  An analytical method for measuring dopa and some metabolites in urine and plasma of Parkinsonian patients.

Authors:  H E Spiegel; R P Christian
Journal:  Clin Chim Acta       Date:  1971-01       Impact factor: 3.786

5.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

Review 6.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

7.  Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).

Authors:  F McDowell; J E Lee; T Swift; R D Sweet; J S Ogsbury; J T Kessler
Journal:  Ann Intern Med       Date:  1970-01       Impact factor: 25.391

8.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15

9.  Treatment of Parkinsonism with Laevo-dopa.

Authors:  C Mawdsley
Journal:  Br Med J       Date:  1970-02-07

Review 10.  L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262

View more
  1 in total

Review 1.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.